Accueil
Détail de l'auteur
Auteur J. MOUNTENEY |
Documents disponibles écrits par cet auteur (36)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Rapport
OEDT = EMCDDA ; A. PIRONA ; L. MONTANARI ; I. GIRAUDON ; J. MATIAS ; K. OIEN ; L. VANDAM ; T. SURMONT ; B. GUARITA ; F. MATHIS ; J. MOUNTENEY ; K. NATONIEWSKA ; S. SLEIMAN ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Ad hoc publication | 2021Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and dru[...]Article : Périodique
May 2014 saw the launch of the European drug report (EDR), the European Monitoring Centre for Drugs and Drug Addiction's (EMCDDAs) annual review of the European drug market, incorporating trend analysis, topic overviews, statistical data and ind[...]Article : Périodique
T. SEYLER ; I. GIRAUDON ; A. NOOR ; J. MOUNTENEY ; P. GRIFFITHS |This paper addresses the question of whether Europe is facing an opioid epidemic and utilises data from the European monitoring system on opioid use, harms and availability, to help assess the situation. Data sources covering the last decade on [...]Article : Périodique
INTRODUCTION: Wastewater-based epidemiology (WBE) has emerged as a timely, non-invasive, and cost-effective indicator of illicit drug consumption. It is increasingly used by international organizations as a proxy measure for estimates of drug pr[...]Article : Périodique
J. MOUNTENEY ; M. STOOVE ; S. HAUGLAND |Within the drug trend monitoring arena, there is an increasing emphasis on the need for more timely identification and reporting of new patterns in drug consumption for policy-making purposes. However, there are documented problems with establis[...]Article : Périodique
A. PIRONA ; A. BO ; D. HEDRICH ; M. FERRI ; N. VAN GELDER ; I. GIRAUDON ; L. MONTANARI ; R. SIMON ; J. MOUNTENEY |Background: The availability of new psychoactive substances (NPS) in Europe has rapidly increased over the last decade. Although prevalence levels of NPS use remain low in the general European population, there are serious concerns associated wi[...]NouveautéRapport
OEDT = EMCDDA ; L. VANDAM ; P. BORLE ; L. MONTANARI ; T. SURMONT ; A. PIRONA ; D. HEDRICH ; A. GALLEGOS ; N. SINGLETON ; J. MOUNTENEY ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2018This report looks at the use of new psychoactive substances (NPS) in prison settings. This is a rapidly developing phenomenon, but empirical data are currently scarce and patchy. There is growing evidence that NPS are responsible for a large sha[...]Article : Périodique
J. MOUNTENEY ; P. GRIFFITHS ; A. BO ; A. CUNNINGHAM ; J. MATIAS ; A. PIRONA |This paper explores the recent resurgence in use of ecstasy/MDMA in Europe and highlights keys areas of continuity and divergence between the ecstasy market of the 1990s and the current MDMA market. Based on a scoping study involving a targeted [...]NouveautéPériodique
J. MOUNTENEY | 1996FRANÇAIS : La stratégie de lutte contre la drogue mis en place par le gouvernement britanique est en place depuis 2 ans. L'auteur, chercheur à l'ISDD donne une vue d'ensemble sur les différentes initiatives issues de cette stratégie telles que [...]Périodique
J. MOUNTENEY ; LEIRVAG S. E. | 2004ENGLISH : In 2002 the Bergen Clinics Foundation established Fore Var, a citywide 'earlier warning' system geared towards the identification, monitoring and reporting of drug and alcohol trends in the city of Bergen, Norway, on a six-monthly ba[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; A. BO ; A. CUNNINGHAM ; I. GIRAUDON ; J. MATIAS ; A. PIRONA ; N. VAN GELDER ; A. RYBARSKA ; L. VANDAM ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2016This report explores the recent resurgence in use of MDMA in Europe and increased availability of high-strength MDMA tablets, crystals and powders. It notes that the picture is not uniform across European countries, and while overall the region’[...]Article : Périodique
The rapid growth in marketing cannabidiol poses a challenge to current European regulatory frameworks that can have important implications for consumer safety, public health, and established industries.Article : Périodique
C. COSTA STORTI ; A. L. BRETTEVILLE-JENSEN ; P. DE GRAUWE ; K. MOELLER ; J. MOUNTENEY ; A. STEVENS |The ongoing COVID-19 pandemic is likely to have a profound impact on the lives of high-risk drug users and on the services responding to their needs in at least two important ways: first, through the restrictive measures introduced to mitigate t[...]Article : Périodique
J. MOUNTENEY ; P. GRIFFITHS ; R. SEDEFOV ; A. NOOR ; J. VICENTE ; R. SIMON |Aim: A central task for the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is to produce an annual report of the latest data available on drug demand and drug supply in Europe. This paper is intended to facilitate a better unde[...]Article : Périodique
L. MONTANARI ; A. PIRONA ; B. GUARITA ; D. HEDRICH ; J. MOUNTENEY ; J. VICENTE |ENGLISH: OBJECTIVE: The article describes an epidemiological indicator called Treatment Demand Indicator (TDI). The TDI aims to provide professionals and researchers with a common European methodology for collecting and reporting core data on d[...]